# Laborie to acquire JADA System from Organon for up to $465M

Laborie Medical Technologies agreed to acquire the JADA System, an FDA-cleared device for postpartum hemorrhage control, from Organon. The transaction is valued up to $465 million, with $440 million at closing and a $25 million milestone payment, expected to close in Q1 2026.

- Type: Acquisition
- Announced: 2025-11-07
- Where: United States
- Value: $465.0M
- Status: announced
- Products: JADA System for postpartum hemorrhage control
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Laborie Medical Technologies](https://endata.com/companies/30706.md) (acquirer)
- [Organon](https://endata.com/companies/54113.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/laborie-announces-agreement-to-acquire-the-jada-system-from-organon-302608618.html), 2025-11-07: "Laborie announced it has entered into an agreement with Organon... to acquire the JADA System."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.